SZPITAL BRZOZÓW

What SZPITAL BRZOZÓW does

Szpital Specjalistyczny w Brzozowie (Szpital Brzozów), formally known as Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, is a publicly owned multi-specialty regional hospital in Brzozów, Poland, established in 1950 and operating as the designated oncology center for the Podkarpackie voivodeship since 1992. The hospital runs a vertically integrated oncology care platform spanning surgical oncology, medical oncology, chemotherapy day-ward, hematology with clinical transplantation, radiotherapy, brachytherapy, and palliative medicine, supported by in-house diagnostics including molecular diagnostics/cytogenetics/cytometry, radiology (CT/MRI/PET), pathomorphology, microbiology, and a transfusion blood bank.

Its radiotherapy technology is anchored on three Elekta linear accelerators (one Synergy, two Versa HD) with the MOSAIQ treatment management system, delivering advanced modalities including 3D-CRT, IMRT, VMAT, IGRT, and 4D respiratory-gated radiotherapy. Brachytherapy is delivered via MicroSelectron V3 HDR and Flexitron HDR afterloaders in dedicated Class Z isotope facilities licensed by the Polish Atomic Energy Agency. Beyond oncology, the hospital provides a full general-hospital portfolio: emergency department (SOR), cardiology with a cardio-oncology subdivision, neurology with stroke unit, gynecology-oncology, orthopedics, pediatrics, neonatology, internal medicine, mental health, addiction therapy, rehabilitation, and home hospice.

The business model is a publicly funded healthcare operator: primary revenue comes from service contracts with Narodowy Fundusz Zdrowia (NFZ), Poland's national health insurer, with secondary fee-for-service revenue for non-NFZ services per a public price list (Cennik). Patients access services via NFZ referrals, GP recommendations, emergency presentation, or direct specialist-clinic registration. The hospital holds ISO 9001:2015 certification, Polish Ministry of Health hospital accreditation, and a Breast Cancer Unit (BCU) designation. It is governed by the Starostwo Powiatowe w Brzozowie (Brzozów District Government) and is currently executing a 300 million PLN expansion of the oncology center announced in June 2026.

Name

SZPITAL BRZOZÓW

Legal name

Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza

Website

https://szpital-brzozow.pl

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

11–50 employees

Short description

Szpital Specjalistyczny w Brzozowie is a publicly owned Polish regional hospital and the designated oncology center for Podkarpackie voivodeship, delivering radiotherapy, brachytherapy, chemotherapy, hematology, and general hospital services to the southeastern Polish population under NFZ public insurance contracts.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), General Medical and Surgical Hospitals (622110), Offices of Physicians (62111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFAHAC

Oncology & Cancer Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

SECONDARYHLAKAJAD

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAKALAK

Orthopedic Oncology (Musculoskeletal Tumors)

Healthcare & Life Sciences/Specialist Medical Practice/Orthopedics & Sports Medicine

SECONDARYHLAKAMAF

Head & Neck Surgery (ENT Oncology)

Healthcare & Life Sciences/Specialist Medical Practice/Otolaryngology (ENT)

Keywords

• Oncology hospital services
• Radiotherapy treatment
• Brachytherapy services
• Clinical oncology care
• Emergency medical care

Headquarters

HQ city

Brzozów

HQ country

Poland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Publicly Funded Healthcare Services (NFZ): The hospital operates as a public healthcare facility under contract with Narodowy Fundusz Zdrowia (NFZ), Poland's national health insurer. Services are reimbursed based on contracted rates and volume for covered populations in the Podkarpackie region.
2. Patient Fee-for-Service: Revenue from services not covered by NFZ, including private consultations, certain procedures, and services listed in the hospital's public price list (Cennik).

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Szpital Specjalistyczny w Brzozowie is a public multi-specialty hospital in Brzozów, Poland, operating as the Podkarpacki Ośrodek Onkologiczny (Subcarpathian Oncological Center) — the designated regional oncology center for the Podkarpackie voivodeship. The hospital delivers comprehensive cancer care (radiotherapy, brachytherapy, chemotherapy, surgical oncology, hematology with transplantology, palliative medicine) alongside general hospital services (emergency care, cardiology, neurology, orthopedics, pediatrics, gynecology, rehabilitation, mental health) and diagnostic services (molecular diagnostics, radiology/imaging, pathology, microbiology, blood bank, endoscopy).

Product overview

Szpital Specjalistyczny w Brzozowie is a multi-specialty hospital functioning as the Podkarpacki Ośrodek Onkologiczny (Subcarpathian Oncological Center). The facility operates on a platform-plus-services model, combining core oncological care (chemotherapy, radiotherapy, brachytherapy, surgical oncology, hematology with transplantology, palliative medicine) with comprehensive diagnostic services (radiology with CT/MRI/PET imaging, molecular diagnostics, pathology, microbiology, blood bank, endoscopy) and supporting services (emergency care, cardiology, rehabilitation, mental health, home hospice). The center is equipped with three Elekta linear accelerators for advanced radiotherapy including IMRT, VMAT, IGRT, and 4D techniques.

Differentiator

Problem solved

Functional benefit

Products and services

• Podkarpacki Ośrodek Onkologiczny (Subcarpathian Oncological Center) Comprehensive regional oncology center providing cancer treatment including chemotherapy, clinical oncology, surgical oncology, hematological oncology with transplantology, radiotherapy, and palliative medicine, serving patients in the Podkarpackie voivodeship.
• Zakład Radioterapii (Radiotherapy Department) Radiotherapy department equipped with three Elekta linear accelerators (Synergy, two Versa HD) offering external beam radiotherapy for all organ locations, including 3D-CRT, IMRT, VMAT, IGRT, and 4D-GRT techniques.
• Zakład Brachyterapii (Brachytherapy Department)
• Breast Cancer Unit (BCU)
• Oddział Dzienny Chemioterapii i Hematologii (Day Ward for Chemotherapy and Hematology)
• Szpitalny Oddział Ratunkowy (Hospital Emergency Department)
• Oddział Kardiologii z Pododdziałem Kardioonkologii i Pracownią Elektroterapii (Cardiology Department with Cardio-oncology Subdivision)
• Laboratorium Diagnostyki Molekularnej, Cytogenetyki i Cytometrii (Molecular Diagnostics, Cytogenetics and Cytometry Laboratory)
• Zakład Radiologii i Diagnostyki Obrazowej (Radiology and Imaging Diagnostics Department)
• Zakład Patomorfologii (Pathomorphology Department)
• Powiatowe Centrum Zdrowia Psychicznego (District Mental Health Center)
• Hospicjum Domowe (Home Hospice)
• Programy profilaktyczne (Cancer Prevention Programs)
• Zakład Rehabilitacji Leczniczej (Medical Rehabilitation Department)

Quantifiable outcome

• Radiotherapy operations have been verified to have no negative impact on public health or environment per Polish Atomic Energy Agency reporting.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Narodowy Fundusz Zdrowia (NFZ)coreOthersNFZ is the national health insurer that contracts the hospital to provide publicly funded healthcare services to insured Polish citizens. This is the primary revenue and patient referral relationship.
• Ministerstwo Zdrowia (Ministry of Health)coreOthersGovernment ministry overseeing healthcare policy, hospital regulation, accreditation, and public health programs. The hospital participates in national prevention programs administered by the ministry.
• Starostwo Powiatowe w Brzozowie (Brzozów District Government)minorOthersLocal district government that owns and oversees the hospital as a public healthcare institution.
• Fundacja Promocji Zdrowia (Health Promotion Foundation)minorStrategic or Co-development PartnerHospital-affiliated foundation supporting health promotion activities, patient support, and community health initiatives. Linked via hospital website.
• Stowarzyszenie SanitasminorStrategic or Co-development PartnerHealth-related association linked to the hospital, supporting healthcare mission and community health activities.
• Fundacja DKMSminorStrategic or Co-development PartnerDKMS is an international bone marrow donor center. The hospital's Hematology Clinic received acknowledgment from DKMS for its clinical work in stem cell and bone marrow transplantation.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Others

• Elekta (vendor reference): Swedish manufacturer of the linear accelerators (Versa HD, Synergy) and brachytherapy systems (Flexitron, MicroSelectron) used by the hospital. Included as a technology/ecosystem reference rather than a competitor.

Direct peers

• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy (Warsaw): Poland's flagship national oncology research institute and hospital in Warsaw. Directly comparable as a multi-modality oncology specialty hospital offering surgical, medical, radiation and hematology oncology with research and advanced treatment programs.
• Wielkopolskie Centrum Onkologii (Poznań): Regional oncology center for the Wielkopolskie voivodeship. Directly comparable as a designated regional oncology center with radiotherapy, brachytherapy, surgical oncology, and hematology programs.
• Zachodniopomorskie Centrum Onkologii (Szczecin): Regional oncology center for Zachodniopomorskie. Comparable publicly-funded oncology specialty hospital operating under NFZ contracts with similar service portfolio.
• Centrum Onkologii Ziemi Lubelskiej (Lublin): Regional oncology center for the Lubelskie voivodeship. Comparable as a public specialty oncology hospital with radiotherapy, chemotherapy, hematology, and oncological surgery departments.
• Narodowy Instytut Onkologii – Oddział w Gliwicach: Gliwice branch of the national oncology institute, one of Poland's largest radiotherapy and brachytherapy centers. Closely comparable on advanced radiotherapy and oncology specialty hospital capability.
• Świętokrzyskie Centrum Onkologii (Kielce): Regional oncology center for Świętokrzyskie. Comparable as a multi-specialty public oncology hospital providing radiotherapy, chemotherapy, and surgical oncology under NFZ contracts.
• Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii (Wrocław): Regional specialty hospital in Wrocław providing oncology, pulmonology, and hematology services. Comparable on multi-modality oncology specialty hospital operations.
• Krakowskie Centrum Onkologii (KCO): Regional specialty oncology hospital in Kraków serving Małopolska. Provides the same vertically integrated oncology services (radiotherapy, chemotherapy, surgical oncology, hematology) under NFZ funding.

Broad incumbents

• Uniwersyteckie Centrum Kliniczne (Gdańsk) – Klinika Onkologii i Radioterapii: Large university hospital in Gdańsk with a major oncology and radiotherapy department. Comparable as a higher-tier competitor offering advanced radiotherapy and clinical trials that may attract patients from regional centers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/szpital-brzoz%C3%B3w

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SZPITAL BRZOZÓW